Aadi Bioscience Stock Current Valuation
| AADI Stock | USD 2.88 0.01 0.35% |
Valuation analysis of Aadi Bioscience helps investors to measure Aadi Bioscience's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Aadi Bioscience's price fluctuation is dangerous at this time. Calculation of the real value of Aadi Bioscience is based on 3 months time horizon. Increasing Aadi Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Aadi Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aadi Stock. However, Aadi Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.88 | Real 2.86 | Hype 2.88 | Naive 2.72 |
The intrinsic value of Aadi Bioscience's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Aadi Bioscience's stock price.
Estimating the potential upside or downside of Aadi Bioscience helps investors to forecast how Aadi stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aadi Bioscience more accurately as focusing exclusively on Aadi Bioscience's fundamentals will not take into account other important factors: Aadi Bioscience Company Current Valuation Analysis
Aadi Bioscience's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Aadi Bioscience Current Valuation | 9.41 M |
Most of Aadi Bioscience's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aadi Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Aadi Bioscience has a Current Valuation of 9.41 M. This is 99.93% lower than that of the Biotechnology sector and 99.8% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
Aadi Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aadi Bioscience's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aadi Bioscience could also be used in its relative valuation, which is a method of valuing Aadi Bioscience by comparing valuation metrics of similar companies.Aadi Bioscience is currently under evaluation in current valuation category among its peers.
Aadi Fundamentals
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (2.46) % | ||||
| Operating Margin | (1.49) % | ||||
| Current Valuation | 9.41 M | ||||
| Shares Outstanding | 24.68 M | ||||
| Shares Owned By Insiders | 11.59 % | ||||
| Shares Owned By Institutions | 53.64 % | ||||
| Number Of Shares Shorted | 472.65 K | ||||
| Price To Book | 1.03 X | ||||
| Price To Sales | 2.84 X | ||||
| Revenue | 24.35 M | ||||
| Gross Profit | (27.54 M) | ||||
| EBITDA | (65.36 M) | ||||
| Net Income | (65.77 M) | ||||
| Cash And Equivalents | 118.74 M | ||||
| Cash Per Share | 5.65 X | ||||
| Total Debt | 1.27 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 9.87 X | ||||
| Book Value Per Share | 2.80 X | ||||
| Cash Flow From Operations | (59.66 M) | ||||
| Short Ratio | 0.55 X | ||||
| Earnings Per Share | (2.28) X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 53 | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 71.08 M | ||||
| Total Asset | 132.42 M | ||||
| Retained Earnings | (268.96 M) | ||||
| Working Capital | 98.19 M | ||||
| Net Asset | 132.42 M |
About Aadi Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aadi Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aadi Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aadi Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out Aadi Bioscience Piotroski F Score and Aadi Bioscience Altman Z Score analysis. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.